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The relationship between obesity and prostate




Recent studies demonstrated that obesity is associated with prostate cancer aggressiveness and prognosis.
However, the mechanisms underlying this relationship are poorly understood. Tumor microenvironment has been
increasingly considered as an important determinant of cancer growth and progression. In the light of this
growing evidence, Ribeiro et al., in a BMC Medicine research article, investigated the gene expression profiles of
periprostatic adipose tissue of obese patients with and without prostate cancer and compared them to those of
lean patients. Their findings provide the first evidence of a differential gene expression in the periprostatic adipose
tissue of obese individuals. Differences were also observed when comparing the periprostatic adipose tissue of
patients with and without prostate cancer. Differentially expressed genes are related to cell proliferation and
immunological responses. Besides suggesting the genetic bases for the observed relationship between obesity and
prostate cancer aggressiveness, these findings provide new insights on the important link between local
microenvironment and cancer progression.
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Background
Obesity represents a well-recognized risk factor in several
malignancies, such as gastroenteric tract cancers. Conver-
sely, the relationship between prostate cancer and obesity
is still a matter of debate. Recent studies showed that obe-
sity is related to higher prostate cancer grade and stage, as
well as to worse oncological outcomes [1-4].
Emerging data suggest the importance of the interactions
between cells in the microenvironment and tumor cells to
determine cancer growth and progression [5]. When focus-
ing on the prostate, periprostatic (PP) adipose tissue repre-
sents the first structure outside the organ capsule; its
infiltration by tumor cells has a detrimental effect on the
prognosis of patients with prostate cancer [6]. To date,
only a few studies investigated the interactions between the
adipose microenvironment and prostate cancer cells [7-9].
These studies concluded that PP adipose tissue may play
an important role by releasing cytokines and growth fac-
tors, such as interleukin-6 and matrix metalloproteinases,
that may promote tumor cell proliferation and migration.
These interactions may have a key-role in determining
prostate cancer aggressiveness and progression.
However, to date, no studies have investigated whether
the relationship between prostate cancer and obesity may
be attributable to changes in the genetic characteristics of
PP adipose tissue of obese individuals. Ribeiro et al. [10]
have attempted to answer this question by determining
the gene expression profiles of PP adipose tissue of obese
individuals and comparing them with those of lean
patients with or without prostate cancer.
Obesity and prostate cancer: unraveling the
mechanisms behind the association
While growing evidence suggests an important link
between obesity and several human malignancies, the
mechanisms underlying this relationship are still poorly
understood. In the current study, evaluation of the PP
adipose tissue of 18 patients (6 with benign prostatic
hyperplasia, 6 with organ-confined prostate cancer and
6 with extra-prostatic prostate cancer) was performed.
Tissue samples were collected during surgery. In each
group, three patients were lean and three patients wereCorrespondence: lughezzani.giovanni@hsr.it
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obese/overweight. The authors identified several genes
differentially expressed in the PP adipose tissue of obese
patients (for example, FADS1, LEP and ANGPT1). These
genes are mainly related to anti-lipolytic, lipogenic, pro-
liferative and anti-apoptotic activities. Genes linked to
the inflammatory response (for example, NPY1R and
FADS1), were also differentially expressed in the PP adi-
pose tissue of obese patients, thus determining a favor-
able environment for disease progression.
Similarly, the authors showed that several genes involved
in cell cycle and proliferation, as well as those involved in
adipocytes differentiation (for example, PLCB1 and
FFAR2) were differentially expressed in the PP adipose tis-
sue of prostate cancer patients, determining an increase in
its thickness. These findings are particularly interesting in
light of a recent study that showed a relationship between
PP adipose tissue thickness and prostate cancer aggressive-
ness [11]. In addition, up-regulation of genes that reduce
immunosurveillance, which may favor prostate cancer pro-
gression, was also observed.
Taken together, these findings provide new insights into
the importance of PP adipose tissue in creating a favorable
environment for prostate cancer cells proliferation and
disease progression.
To date, only a few studies have examined the link
between PP adipose tissue and prostate cancer. Finley
et al. observed an increase in interleukin-6 (IL-6) in the
PP adipose tissue of prostate cancer patients relative to
individuals without prostate cancer [7]. In addition, IL-6
levels correlated with tumor grade [7]. Similarly, Ribeiro
et al. showed that the PP adipose tissue may modulate
prostate cancer cells’ growth and migration through a
local increased activity of matrix metalloproteinase
(MMP) [8]. Finally, Sacca et al. confirmed these observa-
tions by demonstrating an increased secretion of pro-
MMP-9 by the PP adipose tissue of patients with PCa [9].
These findings confirmed the fundamental role of local
microenvironment in determining cancer cells prolifera-
tion and migration.
However, the mechanisms regulating the secretion of
cytokines and growth factors by PP adipose tissue are still
largely unknown. In the current study, several genes differ-
entially expressed both by the PP adipose tissue of obese
patients and by the PP adipose tissue of prostate cancer
patients were identified, suggesting that pathways involved
in cell growth and proliferation, as well as in immunologi-
cal responses, may be altered in these individuals. Based
on their findings, the authors hypothesize a “cross-talk”
mechanism between PP adipose tissue and cancer cells
that may ultimately result in more aggressive prostate can-
cer and promote disease progression, especially in obese
patients.
While this hypothesis should be interpreted with cau-
tion due to the small number of patients included in the
current preliminary study, these findings provide impor-
tant evidence regarding the key role of the adipose
microenvironment in determining prostate cancer
aggressiveness and tumor progression, and shed light on
the genetic pathways that may be involved in the com-
plex relationship between obesity and prostate cancer.
Future directions and conclusions
The differential expression of several genes represents the
key for identifying pathways involved with cancer cell pro-
liferation and tumor progression. In this light, the impor-
tance of the current study is at least two-fold. First, Ribeiro
et al. demonstrated a different gene expression in obese
patients relative to lean patients, irrespective of the pre-
sence of prostate cancer. By showing an up-regulation of
genes related to lypolitic, lipogenic, proliferative and anti-
apoptotic activities in obese patients, this study provides
the first genetic explanations for the observed relationship
between obesity and prostate cancer aggressiveness.
Second, the authors demonstrated different gene signatures
in the PP adipose tissue of prostate cancer patients, sug-
gesting the presence of a “cross-talk” mechanism between
tumor cells and adipose tissue cells to create a favorable
environment to prostate cancer progression.
These findings should promote future studies to further
investigate the relationship between local microenviron-
ment and cancer cell growth. The genetic pathways that
were identified in the current study may represent poten-
tial objectives for targeted therapies. In addition, gene
expression profiles may also be used to better stratify the
prognosis of patients with prostate cancer. Finally, the bet-
ter understanding of the PP adipose tissue biology may
further promote the development of chemo-preventive
strategies and lifestyle measures meant to reduce the num-
ber of life-threatening prostate cancers.
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